We must not let protestors derail trials of pre-exposure prophylaxis for HIV.
Lange
Joep M A
JM
Center for Poverty-Related Communicable Diseases, Academic Medical Center, University of Amsterdam, The Netherlands. j.lange@amc.uva.nl
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015658:HIV Infections / Q000517:prevention & control*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D063065:Organophosphonates / Q000627:therapeutic use*; D011639:Public Opinion; D011640:Public Policy; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000068698:Tenofovir
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000068698:Tenofovir; D000225:Adenine